Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders
Sweden
04030912.2
Filed on 1994-10-12
04030912.2
Filed on 1994-10-12
Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders
Serbia
04030912.2
Filed on 1994-10-12
04030912.2
Filed on 1994-10-12
Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders
Romania
04030912.2
Filed on 1994-10-12
04030912.2
Filed on 1994-10-12
Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders
Portugal
04030912.2
Filed on 1994-10-12
04030912.2
Filed on 1994-10-12
Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders
Poland
04030912.2
Filed on 1994-10-12
04030912.2
Filed on 1994-10-12
Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders
The Netherlands
04030912.2
Filed on 1994-10-12
04030912.2
Filed on 1994-10-12
Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders
Malta
04030912.2
Filed on 1994-10-12
04030912.2
Filed on 1994-10-12
Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders
North Macedonia
04030912.2
Filed on 1994-10-12
04030912.2
Filed on 1994-10-12
Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders
Monaco
04030912.2
Filed on 1994-10-12
04030912.2
Filed on 1994-10-12
Phenylacetate and Derivatives Alone or in Combination with Other Compounds Against Neoplastic Conditions and Other Disorders
Latvia
04030912.2
Filed on 1994-10-12
04030912.2
Filed on 1994-10-12